Evidence map›Paper›PMID 32085975›Full record

ArticleBiomaterials2020

Adverse effects of Alport syndrome-related Gly missense mutations on collagen type IV: Insights from molecular simulations and experiments.

Jingjie Yeo, Yimin Qiu, Gang Seob Jung, Yong-Wei Zhang, Markus J Buehler, David L Kaplan

Open access · greenAbstract read
In one paragraph

Article in Biomaterials, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 29 citations in OpenAlex.

  1. Multi-omics insights into the mechanisms and prognosis of IPF.Genes and environment : the official journal of the Japanese Environmental Mutagen Society · 2026
    Review
  2. Article
  3. Basement membranes at a glance.Journal of cell science · 2025
    Review
  4. Article
  5. Genotype-Based Molecular Mechanisms in Alport Syndrome.Journal of the American Society of Nephrology : JASN · 2025
    Review
  6. Article
  7. Review
  8. A Deeper Insight intoMolecular syndromology · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Identification of a novel pathogenicBiomedical reports · 2021
    Article
  15. Article
  16. Article
  17. Novel Digenic Variants inCase reports in nephrology and dialysis
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Jingjie YeoDepartment of Biomedical Engineering, Tufts University, 4 Colby Street, Medford, MA 02155, USA; Laboratory for Atomistic and Molecular Mechanics (LAMM), Department of Civil and Environmental Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Institute of High Performance Computing, A*STAR, 1 Fusionopolis Way, Singapore 138632, Singapore; Sibley School of Mechanical and Aerospace Engineering, Cornell University, Ithaca, NY 14853, USA.
Yimin QiuDepartment of Biomedical Engineering, Tufts University, 4 Colby Street, Medford, MA 02155, USA; National Biopesticide Engineering Technology Research Center, Hubei Biopesticide Engineering Research Center, Hubei Academy of Agricultural Sciences, Biopesticide Branch of Hubei Innovation Centre of Agricultural Science and Technology, Wuhan, 430064, PR China.
Gang Seob JungLaboratory for Atomistic and Molecular Mechanics (LAMM), Department of Civil and Environmental Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Yong-Wei ZhangInstitute of High Performance Computing, A*STAR, 1 Fusionopolis Way, Singapore 138632, Singapore.
Markus J BuehlerLaboratory for Atomistic and Molecular Mechanics (LAMM), Department of Civil and Environmental Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. Electronic address: mbuehler@mit.edu.
David L KaplanDepartment of Biomedical Engineering, Tufts University, 4 Colby Street, Medford, MA 02155, USA. Electronic address: david.kaplan@tufts.edu.
Massachusetts Institute of Technology · USHubei Academy of Agricultural Sciences · CNInstitute of High Performance Computing · SGTufts University · US

Funding

Models to Predict Protein Biomaterial PerformanceU01EB014976 · NIBIB · TUFTS UNIVERSITY MEDFORD · PI BUEHLER, MARKUS J., KAPLAN, DAVID L. · 2012 to 2020
$5.2M
NIBIB NIH HHS U01 EB014976
6 · The paper itself

Abstract

Patients with Alport syndrome (AS) exhibit blood and elevated protein levels in their urine, inflamed kidneys, and many other abnormalities. AS is attributed to mutations in type IV collagen genes, particularly glycine missense mutations in the collagenous domain of COL4A5 that disrupt common structural motifs in collagen from the repeat (Gly-Xaa-Yaa)

Indexed as

Collagen Type IVNephritis, HereditaryAmino Acid SubstitutionGlycineHumansMutation, MissenseCollagen Type IVGlycineAlport syndromeCollagen type IVEnzyme digestionExperimental assaysIntegrin bindingMolecular dynamics simulationStructural stability

Identifiers

PMID32085975
PMCPMC7071996
OpenAlexW3006159354

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.